PAK2 has both functional redundancies with the other group I PAK family members (PAK1 and 3) plus distinct roles that may jointly contribute to its utility as a target for HPV(−) HNSCC. This evidence concerns the gene PAK2 and head and neck squamous cell carcinoma.